141 related articles for article (PubMed ID: 3161128)
1. [Pharmaco-toxicological aspects of ophthalmological medication].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985; 29(2):135-40. PubMed ID: 3161128
[No Abstract] [Full Text] [Related]
2. [Selected ophthalmological aspects of clinical pharmacology (author's transl)].
Augustyniak E
Klin Oczna; 1977 Apr; 47(4):195-8. PubMed ID: 853681
[No Abstract] [Full Text] [Related]
3. Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops.
Roberts C
Clin Pediatr (Phila); 2002 Apr; 41(3):151-4. PubMed ID: 11999678
[No Abstract] [Full Text] [Related]
4. Drugs and the aging eye.
Dangel ME; Havener WH
Geriatrics; 1981 Mar; 36(3):133-40. PubMed ID: 7215803
[No Abstract] [Full Text] [Related]
5. Side effects of systemic drugs on the eye and of ophthalmic drugs on the body.
el-Naggar AM; Khalil S
Bull Ophthalmol Soc Egypt; 1972; 65(69):563-6. PubMed ID: 4666816
[No Abstract] [Full Text] [Related]
6. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2019; 35(1):1-2. PubMed ID: 30566384
[No Abstract] [Full Text] [Related]
7. Clinical pharmacology of the anterior segment.
Int Ophthalmol Clin; 1980; 20(3):1-194. PubMed ID: 7419370
[No Abstract] [Full Text] [Related]
8. Effect of pathological conditions on drug penetration into the anterior segment.
Foulks GN
Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
[No Abstract] [Full Text] [Related]
9. [Ophthalmic medicinal films].
Maĭchuk IuF; Pozdniakov VI; Khromov G; Koneva EB; Starunova LN
Vestn Oftalmol; 1974; (6):73-6. PubMed ID: 4446241
[No Abstract] [Full Text] [Related]
10. [Problems on pharmaceutical treatment in ophthalmology].
Kirisawa N
Nippon Ganka Gakkai Zasshi; 1968 Oct; 72(10):1966-80. PubMed ID: 5751414
[No Abstract] [Full Text] [Related]
11. Systemic adverse effects of topical ocular treatments.
Labetoulle M; Frau E; Le Jeunne C
Presse Med; 2005 Apr; 34(8):589-95. PubMed ID: 15962500
[TBL] [Abstract][Full Text] [Related]
12. [Experimental ophthalmic anti-inflammatory activity of some steroid and non-steroid drugs topically applied].
Abbondati G; Cornelli U; Preti M; Trimarchi F
Ann Ottalmol Clin Ocul; 1970 Mar; 96(3):161-70. PubMed ID: 5492802
[No Abstract] [Full Text] [Related]
13. Physico-chemical aspects of ophthalmic and contact lens solutions.
Lamy PP; Shangraw RF
Am J Optom Arch Am Acad Optom; 1971 Jan; 48(1):37-51. PubMed ID: 4993499
[No Abstract] [Full Text] [Related]
14. Administering eye medications.
Watkinson S; Seewoodhary R
Nurs Stand; 2008 Jan 9-15; 22(18):42-8. PubMed ID: 18240805
[TBL] [Abstract][Full Text] [Related]
15. [General complications after local pharmacological ophthalmological treatment].
Milkowski S
Wiad Lek; 1968 Dec; 21(23):2127-32. PubMed ID: 4884996
[No Abstract] [Full Text] [Related]
16. [Nipiopharmacology from the ophthalmological point of view].
Gomirato Sandrucci M; Liuzzi L
Minerva Nipiol; 1968; 18(2):48-50. PubMed ID: 5744923
[No Abstract] [Full Text] [Related]
17. [Type IV allergy to components of ophthalmologic drugs].
Riedl B; Reitmeier G; Heese A; Hahn H; Peters KP; Hornstein OP
Klin Monbl Augenheilkd; 1991 Apr; 198(4):251-4. PubMed ID: 1830627
[TBL] [Abstract][Full Text] [Related]
18. Ocular pharmacology and therapeutics.
Evans TM
J Occup Med; 1971 Feb; 13(2):92-6. PubMed ID: 5546201
[No Abstract] [Full Text] [Related]
19. Cardiovascular effects of commonly used ophthalmic medications.
Shiuey Y; Eisenberg MJ
Clin Cardiol; 1996 Jan; 19(1):5-8. PubMed ID: 8903532
[TBL] [Abstract][Full Text] [Related]
20. [Drug-induced complications in ophthalmology].
Lebuisson DA; Aron JJ; Couderc JL
Rev Prat; 1982 Jan; 32(1):57-63. PubMed ID: 7054870
[No Abstract] [Full Text] [Related]
[Next] [New Search]
